Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (e)-n-(2-amino-4-fluorophenyl)-4-((3-(pyridin-3-yl)acrylamido)methyl)benzamide
2. Hbi-8000
1. Epidaza
2. 1616493-44-7
3. Hbi-8000
4. Cs-055
5. Cs055
6. 743438-44-0
7. (e)-n-(2-amino-4-fluorophenyl)-4-((3-(pyridin-3-yl)acrylamido)methyl)benzamide
8. De-5-fluoro 4-fluorochidamide
9. Tucidinostat [usan]
10. Chidamide [who-dd]
11. 87cic980y0
12. Cs 055
13. N-(2-amino-4-fluorophenyl)-4-[[[(e)-3-pyridin-3-ylprop-2-enoyl]amino]methyl]benzamide
14. N-(2-amino-4-fluorophenyl)-4-(((1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)benzamide
15. Benzamide, N-(2-amino-4-fluorophenyl)-4-((((2e)-1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)-
16. Benzamide, N-(2-amino-4-fluorophenyl)-4-(((1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)-
17. Tucidinostat Hcl
18. Epidaza In China
19. Epidaza (tn)
20. Tucidinostat [inn]
21. Tucidinostat [jan]
22. Tucidinostat [who-dd]
23. Unii-87cic980y0
24. Tucidinostat (jan/usan/inn)
25. Chembl3621988
26. Schembl13815849
27. Chebi:135918
28. Dtxsid701032295
29. Ex-a3245
30. Bdbm50457079
31. Db06334
32. Chidamide; Hbi-8000; Cs-055 Hcl
33. Bs-15501
34. Hy-109015
35. Cs-0030513
36. A51185
37. D10993
38. A899933
39. Q19903814
40. Benzamide, N-(2-amino-4-fluorophenyl)-4-(((1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)-benzamide, N-(2-amino-4-fluorophenyl)-4-((((2e)-1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)-
41. N-(2-amino-4-fluorophenyl)-4-(((2e)-3-(pyridin-3-yl)prop- 2-enamido)methyl)benzamide
42. N-(2-amino-4-fluorophenyl)-4-{(3-(pyridin-3-yl)prop-2-enamido)methyl}benzamide N-(2-amino-4-fluorophenyl)-4-{((2e)-3-(pyridin-3-yl)prop-2-enamido)methyl}benzamide
Molecular Weight | 390.4 g/mol |
---|---|
Molecular Formula | C22H19FN4O2 |
XLogP3 | 2.3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 390.14920402 g/mol |
Monoisotopic Mass | 390.14920402 g/mol |
Topological Polar Surface Area | 97.1 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 577 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in cancer/tumors (unspecified).
Chidamide is an orally bioavailable histone deacetylase (HDAC) inhibitor derived from the benzamide class. Histone deacetylase inhibitors are a class of cancer drugs that induce selective regulation of gene expression in cancer cells. [HUYA Biosciences Press Release]
ABOUT THIS PAGE
A Tucidinostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tucidinostat, including repackagers and relabelers. The FDA regulates Tucidinostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tucidinostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tucidinostat supplier is an individual or a company that provides Tucidinostat active pharmaceutical ingredient (API) or Tucidinostat finished formulations upon request. The Tucidinostat suppliers may include Tucidinostat API manufacturers, exporters, distributors and traders.
click here to find a list of Tucidinostat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tucidinostat DMF (Drug Master File) is a document detailing the whole manufacturing process of Tucidinostat active pharmaceutical ingredient (API) in detail. Different forms of Tucidinostat DMFs exist exist since differing nations have different regulations, such as Tucidinostat USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tucidinostat DMF submitted to regulatory agencies in the US is known as a USDMF. Tucidinostat USDMF includes data on Tucidinostat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tucidinostat USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tucidinostat suppliers with USDMF on PharmaCompass.
Tucidinostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tucidinostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tucidinostat GMP manufacturer or Tucidinostat GMP API supplier for your needs.
A Tucidinostat CoA (Certificate of Analysis) is a formal document that attests to Tucidinostat's compliance with Tucidinostat specifications and serves as a tool for batch-level quality control.
Tucidinostat CoA mostly includes findings from lab analyses of a specific batch. For each Tucidinostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tucidinostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Tucidinostat EP), Tucidinostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tucidinostat USP).
LOOKING FOR A SUPPLIER?